Vés al contingut

A SINGLE-ARM, OPEN-LABEL, MULTI-CENTRE, PHASE IB STUDY EVALUATING THE SAFETY AND PRELIMINARY EFFICACY OF AUTO1 IN PAEDIATRIC PATIENTS WITH CD19-POSITIVE RELAPSED/ REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B ALL) AND AGGRESSIVE MATURE B-CELL NON-HODGKIN LYMPHOMA (B NHL)

Obert
  • Codi protocol: AUTO1-PY1
  • Codi EudraCT: No aplica
  • Grup de recerca: Càncer i Malalties Hematològiques Infantils
  • Servei: Oncohematologia Pediàtrica
  • Investigador/a principal:  Díaz de Heredia Rubio, Maria Cristina
  • Malaltia: Tumors
  • Fase: Fase I
  • Estat: Reclutant voluntaris